Related Experiment Video
Updated: Mar 14, 2026

Cerebellar Regional Dissection for Molecular Analysis
Published on: December 5, 2020
RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease
Aurore Nkiliza1, Eugénie Mutez2, Clémence Simonin2
1Univ. Lille, UMR-S 1172 - JPArc - Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer, F-59000 Lille, France; Inserm, UMR-S 1172, Team "Early stages of Parkinson's disease", F-59000 Lille, France.
Abstract:
CAG triplet expansions in Ataxin-2 gene (ATXN2) cause spinocerebellar ataxia type 2 and have a role that remains to be clarified in Parkinson's disease (PD). To study the molecular events associated with these expansions, we sequenced them and analyzed the transcriptome from blood cells of controls and three patient groups diagnosed with spinocerebellar ataxia type 2 (herein referred to as SCA2c) or PD with or without ATXN2 triplet expansions (named SCA2p). The transcriptome profiles of these 40 patients revealed three main observations: i) a specific pattern of pathways related to cellular contacts, proliferation and differentiation associated with SCA2p group, ii) similarities between the SCA2p and sporadic PD groups in genes and pathways known to be altered in PD such as Wnt, Ephrin and Leukocyte extravasation signaling iii) RNA metabolism disturbances with "RNA-binding" and "poly(A) RNA-binding" as a common feature in all groups. Remarkably, disturbances of ALS signaling were shared between SCA2p and sporadic PD suggesting common molecular dysfunctions in PD and ALS including CACNA1, hnRNP, DDX and PABPC gene family perturbations. Interestingly, the transcriptome profiles of patients with parkinsonian phenotypes were prevalently associated with alterations of translation while SCA2c and PD patients presented perturbations of splicing. While ATXN2 RNA expression was not perturbed, its protein expression in immortalized lymphoblastoid cells was significantly decreased in SCA2c and SCA2p versus control groups assuming post-transcriptional biological perturbations. In conclusion, the transcriptome data do not exclude the role of ATXN2 mutated alleles in PD but its decrease protein expression in both SCA2c and SCA2p patients suggest a potential involvement of this gene in PD. The perturbations of "RNA-binding" and "poly(A) RNA-binding" molecular functions in the three patient groups as well as gene deregulations of factors not yet described in PD but known to be deleterious in other neurological conditions, suggest the existence of RNA-binding disturbances as a continuum between spinocerebellar ataxia type 2 and Parkinson's disease.
Insights
CAG triplet expansions in the Ataxin-2 gene (ATXN2) are linked to spinocerebellar ataxia type 2 and Parkinson's disease (PD). Transcriptome analysis reveals shared RNA-binding disturbances and decreased ATXN2 protein in patients, suggesting a continuum between these neurological disorders.
Area of Science:
- Neurogenetics
- Molecular Biology
- Transcriptomics
Background:
- CAG triplet expansions in the Ataxin-2 gene (ATXN2) are causative for spinocerebellar ataxia type 2 (SCA2c).
- The role of ATXN2 expansions in Parkinson's disease (PD) remains unclear.
- Investigating molecular pathways in SCA2c and PD patients with and without ATXN2 expansions is crucial.
Purpose of the Study:
- To analyze transcriptome profiles of blood cells from controls and patients with SCA2c or PD (with/without ATXN2 expansions).
- To identify molecular events and pathways associated with ATXN2 expansions in neurological disorders.
- To explore potential commonalities and differences in molecular dysfunctions between SCA2c and PD.
Main Methods:
- Sequencing of ATXN2 CAG triplet repeats.
- Transcriptome analysis of blood cells from 40 individuals (controls, SCA2c, PD with ATXN2 expansions [SCA2p], sporadic PD).
- Analysis of gene and pathway alterations, including RNA metabolism and protein expression.
Main Results:
- SCA2p patients showed distinct pathways related to cellular contacts, proliferation, and differentiation.
- Similarities in altered genes/pathways (Wnt, Ephrin, Leukocyte extravasation) were observed between SCA2p and sporadic PD.
- Common RNA metabolism disturbances (RNA-binding, poly(A) RNA-binding) were found across all patient groups.
- Shared ALS signaling pathway disturbances between SCA2p and sporadic PD suggest common molecular dysfunctions.
- Decreased ATXN2 protein expression was observed in SCA2c and SCA2p patients, despite normal RNA expression.
- Transcriptome profiles indicated prevalent translation alterations in parkinsonian phenotypes and splicing perturbations in SCA2c and PD patients.
Conclusions:
- Transcriptome data do not exclude a role for mutated ATXN2 alleles in PD.
- Decreased ATXN2 protein expression in SCA2c and SCA2p patients suggests a potential involvement of ATXN2 in PD.
- RNA-binding disturbances represent a potential continuum between SCA2c and PD, highlighting shared molecular mechanisms.
Related Concept Videos
Parkinson's Disease: Overview
Neural Regulation
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Translation
Translation Produces the Building Blocks of Life
Proteins are...

